Company: CERO
Filing Date: 2025-01-07
Form Type: 424B3
Source: 0001213900-25-001661
Chunk: 6

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-01-07
Form: 424B3
Chunk 6
---
 warrants. The shares of Common Stock outstanding following
the Reverse Stock Split remain fully paid and non-assessable. The Reverse Stock Split did not affect the number of authorized shares of
Common Stock or the par value of the Common Stock.

No fractional shares will
be issued in connection with the Reverse Stock Split. Stockholders who would otherwise be entitled to receive fractional shares as a result
of the Reverse Stock Split will automatically be entitled to receive an additional fraction of a share of Common Stock to round up to
the next whole share.

Trading of the Common Stock
on The Nasdaq Global Market commenced on a split-adjusted basis at market open on January 8, under the existing trading symbol “CERO.”
The new CUSIP number for the Company’s Common Stock following the Reverse Stock Split is 71902K303.

The foregoing description
of the Charter Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of the certificate
of amendment, a copy of which is filed as Exhibit 3.1 to this Form 8-K and is incorporated herein by reference.

Item 8.01 Other Events.

On January 6, 2025, the Company issued a press
release announcing the Reverse Stock Split and other related information. A copy of the press release is furnished herewith as Exhibit
99.1 to this Current Report on Form 8-K.

<div align='center'>1</div>

Cautionary Note Regarding Forward Looking Statements

This communication contains
statements that are forward-looking and as such are not historical facts. This includes, without limitation, statements regarding the
Company’s expectations about the effects of the Reverse Stock Split, including the trading of the Company’s common stock on
The Nasdaq Global Market following the Reverse Stock Split. These statements constitute projections, forecasts and forward-looking statements,
and are not guarantees of performance. Such statements can be identified by the fact that they do not relate strictly to historical or
current facts. When used in this communication, words such as “anticipate,” “believe,” “continue,”
“could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,”
“possible,” “potential,” “predict,” “project,” “should,” “strive,”
“would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that
a statement is not forward-looking. When the Company discusses its strategies or plans, it is making